Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding
about
Kupffer cells in the liverBridging Type 2 Diabetes and Alzheimer's Disease: Assembling the Puzzle Pieces in the Quest for the Molecules With Therapeutic and Preventive PotentialRole of NO/VASP Signaling Pathway against Obesity-Related Inflammation and Insulin ResistanceReduced hepatic eNOS phosphorylation is associated with NAFLD and type 2 diabetes progression and is prevented by daily exercise in hyperphagic OLETF ratsEarly life exposure to maternal insulin resistance has persistent effects on hepatic NAFLD in juvenile nonhuman primatesVasodilator-stimulated phosphoprotein protects against vascular inflammation and insulin resistanceDiscovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agentChronic NOS inhibition accelerates NAFLD progression in an obese rat model.Interaction between leucine and phosphodiesterase 5 inhibition in modulating insulin sensitivity and lipid metabolismM2 Macrophage Polarization Mediates Anti-inflammatory Effects of Endothelial Nitric Oxide Signaling.The VASP Road to NAFLD: A Macrophage DetourDeficiency of lymphotoxin-α does not exacerbate high-fat diet-induced obesity but does enhance inflammation in mice.Nitric oxide in liver diseases.VASP increases hepatic fatty acid oxidation by activating AMPK in mice.Redox control of inflammation in macrophages.Recent advances in obesity-induced inflammation and insulin resistance.Combining citrulline with atorvastatin preserves glucose homeostasis in a murine model of diet-induced obesity.Liver innate immune cells and insulin resistance: the multiple facets of Kupffer cells.A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.Heparin modulation on hepatic nitric oxide synthase in experimental steatohepatitisChronic l-arginine treatment improves metabolic, cardiovascular and liver complications in diet-induced obesity in rats.The NOX1 isoform of NADPH oxidase is involved in dysfunction of liver sinusoids in nonalcoholic fatty liver disease.Adipocyte-specific expression of C-type natriuretic peptide suppresses lipid metabolism and adipocyte hypertrophy in adipose tissues in mice fed high-fat diet.Hepatic dysfunction and thrombocytopenia induced by excess sFlt1 in mice lacking endothelial nitric oxide synthase.Effects of ferric citrate supplementation on advanced glycation end products in a rat model of streptozotocin/nicotinamide-induced diabetes.CAV1 Prevents Gallbladder Cholesterol Crystallization by Regulating Biosynthesis and Transport of Bile Salts.Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease.A high throughput, functional screen of human Body Mass Index GWAS loci using tissue-specific RNAi Drosophila melanogaster crosses.
P2860
Q26822031-D999E99F-05AA-429E-A2AE-61ABB5E28F63Q29994589-3452613B-9AAE-4982-962D-C73A56AE34CAQ30234634-A71FB439-DA41-451F-908E-C15F6CA8DC39Q33900501-0F7E48CF-39EC-44A5-B256-ECABC879376DQ33959776-81E9F4E1-BFEB-4FBE-9481-11CE234A3A56Q34295218-0067F209-7C81-4270-8204-1D94DE760998Q34796444-44693BC2-26D4-47A5-B48D-CC9A82982E65Q35178651-A60C1B04-8AF4-49E4-BA59-ED1716C4B790Q35592315-09597E3D-DA2E-44B2-956A-889354796D0CQ35881718-904C254F-5E45-4217-BBAE-CE4F583E60A8Q35881766-468931C7-2B97-4748-A7D4-F8CFEB14E2CEQ35900629-27FE083D-3804-4224-A410-47648312FA7CQ35940869-8B563047-234D-40D6-9701-14C04AA717ACQ36867436-3EC82F62-50C3-41BA-B1A1-705983B42E9CQ37032282-71BA15EF-BFB2-4099-B7F9-CB8323AC87DDQ37080182-7B904BC4-67BA-40F9-AEBB-86D11A8947DEQ38297306-C55737DA-5133-4AF3-8DE8-5F6F9AFEE8BEQ38728754-D5229CC2-8F03-4D3E-8B51-1A39220581B6Q39044686-AB491D96-674F-4460-A0B1-9C73DB2B98D0Q42224390-409C9702-B59E-4437-9B06-215CEB0644FEQ44443067-95E77F61-C545-4277-B240-1CD125EC4E45Q47258601-D456A29E-8DE5-457D-8592-F3A97B8D95E6Q48042234-8B8C43AB-08F2-4CDE-84F0-7D5C070E28B2Q49751930-8FBFBF34-BB88-44C1-9A6B-6215C15720F7Q51318083-336BDF39-BAB3-41A9-8B71-A1A64923E5AAQ53175255-D5533B38-091C-4119-851E-D2CACDF005E7Q54528195-017AA957-9423-4B3E-958C-7BE14C9F0903Q55013662-B1B76353-DB74-4F60-B03A-391EC8A071EF
P2860
Endothelial NO/cGMP/VASP signaling attenuates Kupffer cell activation and hepatic insulin resistance induced by high-fat feeding
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Endothelial NO/cGMP/VASP signa ...... ce induced by high-fat feeding
@ast
Endothelial NO/cGMP/VASP signa ...... ce induced by high-fat feeding
@en
type
label
Endothelial NO/cGMP/VASP signa ...... ce induced by high-fat feeding
@ast
Endothelial NO/cGMP/VASP signa ...... ce induced by high-fat feeding
@en
prefLabel
Endothelial NO/cGMP/VASP signa ...... ce induced by high-fat feeding
@ast
Endothelial NO/cGMP/VASP signa ...... ce induced by high-fat feeding
@en
P2093
P2860
P356
P1433
P1476
Endothelial NO/cGMP/VASP signa ...... ce induced by high-fat feeding
@en
P2093
Alexander W Clowes
Andrew M Cheng
Francis Kim
Gregory J Morton
Guenter Daum
Michael W Schwartz
Norma O Rizzo
Priya Handa
Sanshiro Tateya
Vicki Morgan-Stevenson
P2860
P304
P356
10.2337/DB11-0255
P407
P577
2011-09-12T00:00:00Z